A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Cogent Biosciences, Inc.
Blueprint Medicines Corporation
National Institutes of Health Clinical Center (CC)
Medical University of Graz
Novartis